| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ryerson Holding Corp | Director | Common Stock (par value $0.01 per share) | 2.2K | $51.7K | $23.50 | Oct 1, 2024 | Direct |
| NantHealth, Inc. | Director | Stock Option (right to buy) | 100K | Jun 9, 2022 | Direct | ||
| PLx Pharma Inc. | Director | Stock Option (right to buy) | 20K | Feb 22, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RYI | Ryerson Holding Corp | Oct 1, 2024 | 1 | $0 | 4 | Oct 1, 2024 | Director |
| RYI | Ryerson Holding Corp | Jul 1, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
| RYI | Ryerson Holding Corp | Apr 1, 2024 | 1 | $0 | 4 | Apr 2, 2024 | Director |
| RYI | Ryerson Holding Corp | Jan 12, 2024 | 1 | $0 | 4 | Jan 16, 2024 | Director |
| RYI | Ryerson Holding Corp | Oct 2, 2023 | 1 | $0 | 4 | Oct 3, 2023 | Director |
| NHIQ | NantHealth, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| PLXPQ | PLx Pharma Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Director |
| NHIQ | NantHealth, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jul 26, 2021 | Director |